SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006702
Filing Date
2018-08-08
Accepted
2018-08-08 09:29:56
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20180630x10q.htm 10-Q 2028917
2 EX-31.1 qure-20180630ex311c5d845.htm EX-31.1 18164
3 EX-31.2 qure-20180630ex3129975b9.htm EX-31.2 18066
4 EX-32.1 qure-20180630ex321c6f628.htm EX-32.1 11131
  Complete submission text file 0001558370-18-006702.txt   7505502

Data Files

Seq Description Document Type Size
5 EX-101.INS qure-20180630.xml EX-101.INS 1615603
6 EX-101.SCH qure-20180630.xsd EX-101.SCH 58116
7 EX-101.CAL qure-20180630_cal.xml EX-101.CAL 48907
8 EX-101.DEF qure-20180630_def.xml EX-101.DEF 240902
9 EX-101.LAB qure-20180630_lab.xml EX-101.LAB 515948
10 EX-101.PRE qure-20180630_pre.xml EX-101.PRE 383537
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 181000064
SIC: 2834 Pharmaceutical Preparations